Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 0.54 · gapped below the open, never looked back. High/low 0.52 at 1:45 pm ET, 0.52 at 9:15 am ET.
via Orbimed Advisors LLC, Sphera Funds Management Ltd., ADAR1 Capital Management, LLC +2 more · 19.54% of TRAW, 27.50% of PRLD
via Adage Capital Partners GP, L.L.C., Ikarian Capital, LLC, Sphera Funds Management Ltd. +3 more · 11.86% of TRAW, 14.84% of PRQR
via Adage Capital Partners GP, L.L.C., Ikarian Capital, LLC, Boothbay Fund Management, LLC +1 more · 11.86% of TRAW, 15.97% of NXTC
via Ally Bridge Group (NY) LLC, Sphera Funds Management Ltd., Ikarian Capital, LLC +3 more · 12.77% of TRAW, 9.69% of PMN
via Orbimed Advisors LLC, Ikarian Capital, LLC, Boothbay Fund Management, LLC · 19.54% of TRAW, 18.40% of QTTB
via Orbimed Advisors LLC, Adage Capital Partners GP, L.L.C., Alyeska Investment Group, L.P. · 19.54% of TRAW, 13.71% of ACET
Managers holding a meaningful stake in TRAW also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
Traws Pharma, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
31 institutional managers report a position in Traws Pharma, Inc. worth $5.2M between them, filed on form 13F for the quarter ending 2026-06-30. 8 of them hold 80% of it, the largest being Orbimed Advisors LLC at 19.54%.
6 more managers in the register
8 managers hold 80% of the $5.2M institutional base. The other 23 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
TRAW (Traws Pharma, Inc.) has 2 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.